IL18 and myositis disease: IL-18 levels were determined in two cohorts of patients. In cohort one,10 new-onset myositis patients (IL-18 expression was compared between symptomatic and asymptomatic muscle biopsies that were taken prior to treatment). The second cohort consisted of another 10 patients with repeated muscle biopsies before and after 8 months with conventional immunosuppressive treatment.